Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
KE Transcript
Kimball Electronics, Inc. (KE) Q3 2026 Earnings Call Transcript
Positive5-6
The earnings call summary highlights a strong financial performance with a 10% revenue increase and improved gross margins, leading to a 15% rise in net income. The positive financial metrics, along with increased operating cash flow, suggest a healthy financial position. Despite the absence of detailed strategic initiatives, the financial results and raised guidance for fiscal 2026 are likely to result in a positive stock price movement. However, the lack of additional insights from the Q&A section and strategic updates tempers the rating to 'Positive' instead of 'Strong positive.'
Kimball Electronics, Inc. (KE) Q2 2026 Earnings Call Transcript
Unknown2-5
The earnings call presents a mixed picture: strong growth in the medical segment and improved gross margins are positive, but overall net sales declined, and automotive sales are down. The shareholder return plan is positive, but the Q&A reveals uncertainties about the new facility's impact on margins and revenue. The market reaction is likely to be neutral, with offsetting positive and negative factors balancing each other out.
Kimball Electronics, Inc. (KE) Q1 2026 Earnings Call Transcript
Unknown11-6
The earnings call highlights a mix of positive and negative factors. Strong adjusted income and net income, debt reduction, and cash flow are positives. However, the guidance for fiscal 2026 indicates revenue decline and modest growth in key segments. The Q&A reveals positive sentiment towards medical growth and strategic acquisitions, but concerns in the automotive sector and potential SG&A increase. Overall, the outlook is mixed with stable margins and strategic growth plans, leading to a neutral sentiment.
Kimball Electronics, Inc. (KE) Q4 2025 Earnings Conference Call Transcript
Positive8-14
The earnings call highlights a robust strategy with new facility expansion, strong focus on the medical segment, and margin improvement efforts. The Q&A reveals positive sentiment towards automation and growth initiatives, despite some vague responses on industrial plans. The reiteration of fiscal guidance, coupled with strategic investments in sales and business development, supports a positive outlook. The absence of negative financial surprises and the focus on high-growth segments suggest a positive stock price movement in the short term.
KE Slides
KE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
